CureFit's FY25 Net Loss Plunges 83% to ₹483 Crore on Back of Revenue Growth

Written by: Team Angel OneUpdated on: 14 Mar 2026, 4:04 pm IST
CureFit reduced its FY25 net loss to ₹483 crore, an 83% improvement year-on-year, driven by revenue growth and strategic restructuring.
CureFit's FY25 Net Loss
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

CureFit, the Bengaluru-based health and fitness startup, significantly shrank its net loss by 83% in FY25, bringing it down to ₹483 crore compared to the previous year's ₹888 crore loss. This improvement aligns with the firm's strategic focus on revenue growth and operations restructuring. 

Key Financial Highlights of FY25 

In FY25, CureFit reported a substantial increase in operating revenue, rising 31% to ₹1,215 crore from ₹926.6 crore in FY24. Including additional income of ₹56.4 crore, the startup's total revenue touched ₹1,272 crore for the year. The core of its revenue came from services, which amounted to ₹841.3 crore. Additionally, the direct-to-consumer fitness apparel business contributed ₹326.4 crore. 

Revenue Streams and Strategic Adjustments 

Besides its core fitness services, CureFit earned around ₹50 crore from its franchising model. However, the fiscal year also involved key strategic shifts with the discontinuation of brands like Onyx and Trade.fit, resulting in impairment costs. Intangible assets from these brands were impaired to the tune of ₹10.7 crore for Onyx and ₹27 lakh for Trade.fit. 

Focus on Cost Management 

With a strategic focus on cost efficiency, CureFit managed to keep its expenses in check. Employee expenses rose slightly by 7% to ₹347.4 crore, whereas facility management costs increased by 28% to ₹129.3 crore. Conversely, promotional and advertisement expenses were reduced by 3%, settling at ₹203 crore. 

Operational Streamlining and Impairment Costs 

CureFit saw impairment costs of ₹319.3 crore due to its restructuring efforts, which included sunsetting apps like Fitternity and Fitso. These strategic adjustments were critical in streamlining operations, paving the way for future profitability goals. 

Conclusion 

The reductions in losses and improvements in revenue highlight CureFit’s focused efforts to optimise its operations while navigating significant restructuring activities. The company's strategic adjustments have laid the groundwork for a stronger financial performance in upcoming years. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investin

Published on: Mar 14, 2026, 10:32 AM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3.5 Cr+ happy customers